Why UnitedHealth Stock (UNH) Is Rising Today — And What Raymond James Sees Next

UnitedHealth Group UNH +3.36% ▲ moved higher in pre-market trading on Wednesday after receiving a bullish upgrade from Raymond James, as improving margin trends across its business are becoming clearer. The firm’s top analyst John Ransom upgraded the stock to Outperform (equivalent to Buy) from Market Perform and set a $330 price target, citing better visibility into earnings upside.

End of Quarter Sale - 50% Off TipRanks

• Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions

• Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks

Margin Gains Drive the Bull Case

Ransom believes there is more room than expected to improve general and administrative (G&A) efficiency. Even small margin gains here could have a meaningful impact, with every 100 basis point improvement adding about $3.80 per share.

At the same time, visibility into Optum Health margins has improved. While 2026 margins may appear flat, the underlying trend is getting better as the company exits weaker operations and tightens its network.

Operational Changes Support Margin Outlook

Ransom said this improvement is already being supported by internal changes. UnitedHealth has shut down or sold several smaller clinics that were losing money, which should help ease pressure on margins. At the same time, the company is working to improve profitability in its roughly $58 billion risk-based revenue business, where margins are currently very low, at under 1%.

There is also room for improvement in the $33 billion Optum non-capitation segment. Despite including some higher-margin assets, this business is still generating only mid-single-digit margins, suggesting it could perform better with tighter execution.

Ransom added that even small margin gains across these areas can make a noticeable difference. For example, a 100 basis points improvement in Medicare Advantage margins could add about $1.80 per share, while a similar improvement in Optum Health margins could add around $0.80 per share.

**Is UNH a Good Buy Now? **

Turning to Wall Street, UNH stock has a Strong Buy consensus rating based on 17 Buys, three Holds, and zero Sells assigned in the last three months. At $366.47, the average UnitedHealth stock price target implies a 35.44% upside potential.

Disclaimer & DisclosureReport an Issue